Drug Profile
Semotiadil
Alternative Names: DS 4823; SD 3211; SesamodilLatest Information Update: 03 Jan 2001
Price :
$50
*
At a glance
- Originator Santen Pharmaceutical
- Developer Daiichi Pharmaceutical; Santen Pharmaceutical
- Class Antihypertensives; Ischaemic heart disorder therapies
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Arrhythmias; Hypertension
Most Recent Events
- 03 Jan 2001 Discontinued-II for Angina pectoris in Europe (PO)
- 03 Jan 2001 Discontinued-II for Arrhythmias in Japan (PO)
- 03 Jan 2001 Discontinued-II for Hypertension in Europe (PO)